Key facts
- Decode Health’s last known valuation is $10.0M (Apr 2023).
- It has raised $3.6M; the latest was Grant ($2.0M) in Jul 2025.
- Notable investors include National Institutes of Health.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Decode Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Decode Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Decode Health
Operator of a precision medicine research platform intended to accelerate biomarker discovery and clinical insights. The company offers automated multiomics analysis, proprietary patient data integration, clinical analytics, and structured research workflows, enabling pharmaceutical, diagnostics, and health technology organizations to generate validated findings and support clinical decision-making.
- Sector
- Healthcare
- HQ
- Nashville, TN, United States
- Founded
- 2019
- Employees
- 20
- Website
- decodehealth.ai/
- Ownership
- Privately Held (backing)
Decode Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Decode Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Decode Health in its N-PORT filings yet. We sweep new filings monthly.